ArticleOncology reports2019

Osimertinib (AZD9291) increases radio‑sensitivity in EGFR T790M non‑small cell lung cancer.

Nannan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.